EMEA-000783-PIP01-09-M06
Key facts
| Invented name |
Trulicity
|
| Active substance |
dulaglutide
|
| Therapeutic area |
Endocrinology, -gynacology-fertility-metabolism
|
| Decision number |
P/0409/2021
|
| PIP number |
EMEA-000783-PIP01-09-M06
|
| Pharmaceutical form(s) |
Solution for injection (pre-filled pen)
|
| Condition(s) / indication(s) |
Treatment of type II diabetes mellitus
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Eli Lilly & Company Limited
E-mail: eu_paediatric@lilly.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|